Concepedia

Kristina Dabovic

KD

Statistics

Publications

6

Citations

245

H-Index

6

Active since

2003

Affiliations

Novartis (United States)(Current)

University of Chicago

Albert Einstein College of Medicine

Molecular Templates (United States)

University of Arizona

Kristina Dabovic is an author at Novartis (United States) specializing in pharmacology, antimicrobial pharmacotherapy, and medicine.

Publications per year

2003–2022

6

Publications

6

Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections

Kathleen M. Mullane, Christine Lee, Adam Bressler et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

The Kinetic Mechanism of Phosphomevalonate Kinase

Daniel E. Pilloff, Kristina Dabovic, M.J. Romanowski et al. · Journal of Biological Chemistry · 2003 · 53 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

<i>Streptococcus pneumoniae</i> Isoprenoid Biosynthesis Is Downregulated by Diphosphomevalonate: An Antimicrobial Target

John L. Andreassi, Kristina Dabovic, Thomas S. Leyh · Biochemistry · 2004 · 35 citations

Life Sciences, Microbiology, Molecular Biology +16

Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections

Suraj G. Bhansali, Kathleen M. Mullane, Lillian Ting et al. · Antimicrobial Agents and Chemotherapy · 2014 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma

Paul A. Hamlin, Vasile Musteata, Steven I. Park et al. · Cancer Research Communications · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6